QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class:
|
Trading Symbol(s)
|
Name of each exchange on which registered:
|
||
(including attached preferred stock purchase rights)
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
☒
|
Smaller reporting company
|
|
Emerging growth company
|
|
|
|
Page
|
|
PART I.
|
FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
Item 1.
|
Consolidated Financial Statements (Unaudited)
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
Item 2.
|
23
|
|
|
|
|
|
|
Item 3.
|
35
|
|
|
|
|
|
|
Item 4.
|
35
|
|
|
|
|
|
PART II.
|
OTHER INFORMATION
|
|
|
|
|
|
|
|
Item 1.
|
36 | |
|
|
|
|
|
Item 1A.
|
36
|
|
|
|
|
|
|
Item 2.
|
36 | |
|
|
|
|
|
Item 3.
|
36
|
|
|
|
|
|
|
Item 4.
|
36
|
|
|
|
|
|
|
Item 5.
|
36
|
|
|
|
|
|
|
Item 6.
|
36 | |
|
|
|
|
|
37
|
September 30, 2022
|
December 31, 2021
|
|||||||
(Unaudited)
|
||||||||
Assets:
|
||||||||
Cash and due from banks
|
$
|
|
$
|
|
||||
Interest-bearing deposits in other banks
|
|
|
||||||
Cash and cash equivalents
|
|
|
||||||
Securities available-for-sale, at fair value
|
|
|
||||||
Loans receivable held for investment, net of allowance of $
|
|
|
||||||
Accrued interest receivable
|
|
|
||||||
Federal Home Loan Bank (FHLB) stock
|
|
|
||||||
Federal Reserve Bank (FRB) stock
|
||||||||
Office properties and equipment, net
|
|
|
||||||
Bank owned life insurance
|
|
|
||||||
Deferred tax assets, net
|
|
|
||||||
Core deposit intangible, net
|
||||||||
Goodwill
|
||||||||
Other assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
Liabilities and stockholders’ equity
|
||||||||
Liabilities:
|
||||||||
Deposits
|
$
|
|
$
|
|
||||
Securities sold under agreements to repurchase
|
||||||||
FHLB advances
|
|
|
||||||
Notes payable
|
||||||||
Accrued expenses and other liabilities
|
|
|
||||||
Total liabilities
|
|
|
||||||
Cumulative Perpetual Preferred stock, Series A; authorized
|
|
|
||||||
Non-Cumulative Redeemable Perpetual Preferred stock, Series C;
authorized
|
||||||||
Common stock, Class A, $
|
|
|
||||||
Common stock, Class B, $
|
||||||||
Common stock, Class C, $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Unearned Employee Stock Ownership Plan (ESOP) shares
|
(
|
)
|
(
|
)
|
||||
Accumulated other comprehensive loss, net of tax
|
(
|
)
|
(
|
)
|
||||
Treasury stock-at cost,
|
(
|
)
|
(
|
)
|
||||
Total Broadway Financial Corporation and Subsidiary stockholders’ equity
|
|
|
||||||
Non-controlling interest
|
||||||||
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
Three Months Ended
September 30,
|
Nine
Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Interest income:
|
||||||||||||||||
Interest and fees on loans receivable
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Interest on available-for-sale securities
|
|
|
|
|
||||||||||||
Other interest income
|
|
|
|
|
||||||||||||
Total interest income
|
|
|
|
|
||||||||||||
Interest expense:
|
||||||||||||||||
Interest on deposits
|
|
|
|
|
||||||||||||
Interest on borrowings
|
|
|
|
|
||||||||||||
Total interest expense
|
|
|
|
|
||||||||||||
Net interest income
|
|
|
|
|
||||||||||||
Loan loss provision
|
|
|
|
|
||||||||||||
Net interest income after loan loss provision
|
|
|
|
|
||||||||||||
Non-interest income:
|
||||||||||||||||
Service charges
|
|
|
|
|
||||||||||||
CDFI Grant
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total non-interest income
|
|
|
|
|
||||||||||||
Non-interest expense:
|
||||||||||||||||
Compensation and benefits
|
|
|
|
|
||||||||||||
Occupancy expense
|
|
|
|
|
||||||||||||
Information services
|
|
|
|
|
||||||||||||
Professional services
|
|
|
|
|
||||||||||||
Supervisory costs
|
|
|
|
|
||||||||||||
Office services and supplies
|
|
|
|
|
||||||||||||
Corporate insurance
|
|
|
|
|
||||||||||||
Amortization of core deposit intangible
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total non-interest expense
|
|
|
|
|
||||||||||||
Income (loss) before income taxes
|
|
|
|
(
|
)
|
|||||||||||
Income tax expense (benefit)
|
|
|
|
(
|
)
|
|||||||||||
Net income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||||
Less: Net income attributable to non-controlling interest
|
|
|
|
|
||||||||||||
Net income (loss) attributable to Broadway Financial Corporation
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||||
Other comprehensive income, net of tax:
|
||||||||||||||||
Unrealized gains (losses) on securities available-for-sale arising during the period
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||
Income tax (benefit) expense
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||
Other comprehensive income (loss), net of tax
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||
Comprehensive income (loss)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Earnings (loss) per common share-basic
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||||
Earnings (loss) per common share-diluted
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
Nine Months Ended
September 30, |
||||||||
2022
|
2021
|
|||||||
(In thousands)
|
||||||||
Cash flows from operating activities:
|
||||||||
Net income (loss)
|
$
|
|
$
|
(
|
)
|
|||
Adjustments to reconcile net income (loss) to net cash used in
operating activities:
|
||||||||
Loan loss provision
|
|
|
||||||
Depreciation
|
|
|
||||||
Net change of deferred loan origination costs
|
|
|
||||||
Net amortization of premiums & discounts on
available-for-sale securities
|
|
|
||||||
Amortization of investment in affordable housing limited
partnership
|
|
|
||||||
Amortization of purchase accounting marks on loans
|
(
|
)
|
|
|||||
Amortization of core deposit intangible
|
|
|
||||||
Director compensation expense-common stock
|
|
|
||||||
Accretion of premium on FHLB advances
|
(
|
)
|
(
|
)
|
||||
Stock-based compensation expense
|
|
|
||||||
Valuation allowance on deferred tax asset
|
|
|
||||||
ESOP compensation expense
|
|
|
||||||
Earnings on bank owned life insurance
|
(
|
)
|
(
|
)
|
||||
Change in assets and liabilities:
|
||||||||
Net change in deferred taxes
|
|
(
|
)
|
|||||
Net change in accrued interest receivable
|
( |
) | ||||||
Net change in other assets
|
(
|
)
|
|
|||||
Net change in accrued expenses and other liabilities
|
(
|
)
|
|
|||||
Net cash provided by operating activities
|
|
|
||||||
Cash flows from investing activities:
|
||||||||
Cash acquired in merger
|
|
|
||||||
Net change in loans receivable held for investment
|
(
|
)
|
(
|
)
|
||||
Principal payments on available-for-sale securities
|
|
|
||||||
Purchase of available-for-sale securities
|
(
|
)
|
(
|
)
|
||||
Purchase of FHLB stock
|
(
|
)
|
(
|
)
|
||||
Proceeds from redemption of FHLB stock
|
|
|
||||||
Purchase of office properties and equipment
|
(
|
)
|
(
|
)
|
||||
Proceeds from disposals of office properties and equipment
|
|
|
||||||
Net cash (used in) provided by investing activities
|
(
|
)
|
|
|||||
Cash flows from financing activities:
|
||||||||
Net change in deposits
|
(
|
)
|
|
|||||
Net change in securities sold under agreements to repurchase
|
|
(
|
)
|
|||||
Proceeds from sale of stock (net of costs)
|
|
|
||||||
Proceeds from issuance of preferred stock
|
|
|
||||||
Dividends paid on preferred stock
|
(
|
)
|
(
|
)
|
||||
Distributions to non-controlling interest
|
|
(
|
)
|
|||||
Proceeds from FHLB advances
|
|
|
||||||
Repayments of FHLB advances
|
(
|
)
|
(
|
)
|
||||
Stock cancelled for income tax withholding
|
|
(
|
)
|
|||||
Repayments of junior subordinated debentures
|
|
(
|
)
|
|||||
Net cash provided by financing activities
|
|
|
||||||
Net change in cash and cash equivalents
|
(
|
)
|
|
|||||
Cash and cash equivalents at beginning of the period
|
|
|
||||||
Cash and cash equivalents at end of the period
|
$
|
|
$
|
|
||||
Supplemental disclosures of cash flow
information:
|
||||||||
Cash paid for interest
|
$
|
|
$
|
|
||||
Cash paid for income taxes
|
|
|
||||||
Assets acquired (liabilities assumed) in
acquisition:
|
||||||||
Securities available-for-sale, at fair value
|
$
|
|
$
|
|
||||
Loans receivable
|
|
|
||||||
Accrued interest receivable
|
|
|
||||||
FHLB and FRB stock
|
|
|
||||||
Office property and equipment
|
|
|
||||||
Goodwill
|
(
|
)
|
|
|||||
Core deposit intangible
|
|
|
||||||
Other assets
|
|
|
||||||
Deposits
|
|
(
|
)
|
|||||
FHLB advances
|
|
(
|
)
|
|||||
Securities sold under agreements to repurchase
|
|
(
|
)
|
|||||
Other borrowings
|
|
(
|
)
|
|||||
Deferred taxes
|
|
(
|
)
|
|||||
Accrued expenses and other liabilities
|
|
(
|
)
|
|||||
Preferred stock
|
|
(
|
)
|
|||||
Common stock
|
|
(
|
)
|
Three-Month Period Ended September 30, 2022 and 2021
|
||||||||||||||||||||||||||||||||||||||||
Preferred Stock Non-Voting
|
Common
Stock Voting |
Common
Stock Non-Voting |
Additional
Paid‑in Capital |
Accumulated Other Comprehensive Income (Loss)
|
Retained Earnings
|
Unearned
ESOP Shares |
Treasury
Stock |
Non-Controlling Interest
|
Total
Stockholders’ Equity |
|||||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||||||||||
Balance at July 1, 2022
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||||||||
Net income
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Release of unearned ESOP shares
|
( |
) | ||||||||||||||||||||||||||||||||||||||
Restricted stock compensation expense
|
||||||||||||||||||||||||||||||||||||||||
Conversion of non-voting shares into voting shares
|
( |
) | ||||||||||||||||||||||||||||||||||||||
Other comprehensive loss, net of tax
|
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
Balance at September 30, 2022
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||||||||
Balance at July 1, 2021
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||||||||
Net income
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Preferred shares issued in business combination
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||||||||||||||
Release of unearned ESOP shares
|
||||||||||||||||||||||||||||||||||||||||
Common stock cancelled for payment of tax withholding
|
( |
) |